Price Chart

Profile

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.
URL https://www.verupharma.com
Investor Relations URL https://ir.verupharma.com/
HQ State/Province Florida
Sector Consumer Staples
Industry Personal Care Products
Equity Style Small Cap/Value
Next Earnings Release Feb. 07, 2025 (est.)
Last Earnings Release Aug. 08, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Apr. 28, 2014

Profile

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.
URL https://www.verupharma.com
Investor Relations URL https://ir.verupharma.com/
HQ State/Province Florida
Sector Consumer Staples
Industry Personal Care Products
Equity Style Small Cap/Value
Next Earnings Release Feb. 07, 2025 (est.)
Last Earnings Release Aug. 08, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Apr. 28, 2014